Studying pancreatitis caused by high triglycerides
Part of Digestive system clinical trials.
This study looks at people with acute pancreatitis caused by very high blood fat levels (triglycerides). It aims to collect information to better understand and treat this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with acute pancreatitis (sudden stomach pain, high pancreatic enzyme levels, or typical signs on imaging).
- Your blood triglyceride level was over 500 mg/dL during this episode.
- You are willing to follow the study rules and give your written consent.
- You have not used any cholesterol-lowering medications before this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether an upper endoscopy (a camera test to look inside your stomach and the first part of your small intestine) done within 24-48 hours of being admitted to the hospital can help guide treatment for acute pancreatitis. You may be able to join if you are an adult with a confirmed case of acute pancreatitis and are able to safely undergo this procedure.
This study tests whether a GLP-1 medication (a drug that helps control blood sugar and triglycerides) can prevent pancreatitis from coming back in people who had a severe attack caused by very high triglyceride levels. If it works, it could help you avoid future painful attacks.
This Phase 1 trial tests the safety of a gene therapy for people with inherited, hard-to-control high triglycerides (fat in the blood) who have had pancreatitis episodes. It may help by targeting the genes involved in triglyceride control, but the main goal here is to check safety and tolerability.
This study tests an experimental drug called DR10624 compared to a placebo in people with severely high triglycerides (fats in the blood). It aims to see if the drug can safely lower these fats and reduce the risk of related health problems like pancreatitis.
This trial looks at how severe acute pancreatitis works by using advanced tests on your body's germs, chemicals, and proteins. It may help find better ways to treat patients with this condition.
This study looks at why some people develop diabetes after acute pancreatitis and how that process works in the body. It may help doctors better predict risk and tailor care for people recovering from pancreatitis.
Hear when a new Acute Pancreatitis (AP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.